Stefan Barth
- Immunology top 1%
- Toxin Mechanisms and Immunotoxins 70
- Immunotherapy and Immune Responses 21
- Biotechnology top 0.5%
- Transgenic Plants and Applications 32
-
- Monoclonal and Polyclonal Antibodies Research 100
- Oncology top 2%
- CAR-T cell therapy research 26
- Biochemistry top 2%
-
- Glycosylation and Glycoproteins Research 20
- RNA Interference and Gene Delivery 20
-
- Virus-based gene therapy research 16
- Co-authors
- Rainer FischerMichael HühnMehmet Kemal TurAndreas EngertTheo ThepenAchim BubBernhard WatzlAhmad Fawzi Hussain
- Partner nations
- GermanySouth AfricaUnited States
In The Last Decade
Stefan Barth
247 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 144
- Immunology 1.8k
- Biotechnology 642
- Radiology, Nuclear Medicine and Imaging 1.4k
- Oncology 1.1k
- Biochemistry 207
Countries citing papers authored by Stefan Barth
This map shows the geographic impact of Stefan Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Barth more than expected).
Fields of papers citing papers by Stefan Barth
This network shows the impact of papers produced by Stefan Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Barth. The network helps show where Stefan Barth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan Barth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 10 | |
| 11 | 2020 | 33 | |
| 12 | 2020 | 4 | |
| 13 | 2018 | 79 | |
| 14 | 2017 | 19 | |
| 15 | 2017 | 12 | |
| 16 | 2016 | 8 | |
| 17 | Phototheranostics immunoconjugates to detect eliminate triple negative breast cancer cells | 2016 | 1 |
| 18 | 2014 | 18 | |
| 19 | 2014 | 2 | |
| 20 | [Comparative studies on the vaccination of mice with inactivated influenza virus administered by the aerosol technique, by the intranasal or intramuscular route (author's transl)]. | 1979 | 0 |
About Stefan Barth
Stefan Barth is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 257 papers that have together received 5.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (100 papers), Toxin Mechanisms and Immunotoxins (70 papers), Transgenic Plants and Applications (32 papers), CAR-T cell therapy research (26 papers), Immunotherapy and Immune Responses (21 papers), Glycosylation and Glycoproteins Research (20 papers), RNA Interference and Gene Delivery (20 papers) and Virus-based gene therapy research (16 papers). The work is most often cited by research in Immunology (1.8k citations), Biotechnology (642 citations) and Radiology, Nuclear Medicine and Imaging (1.4k citations). Stefan Barth has collaborated with scholars based in Germany, South Africa and United States. Frequent co-authors include Rainer Fischer, Michael Hühn, Mehmet Kemal Tur, Andreas Engert, Theo Thepen, Achim Bub, Bernhard Watzl, Ahmad Fawzi Hussain, Michael Stöcker and Volker Diehl. Their work appears in journals such as International Journal of Cancer, Biomedicines, Cancer Letters, International Journal of Molecular Medicine and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.